BridgeMD
New treatment option for Tension-Type Headache Episodic
Official title Pilot Study of the Osteo-Fluidic-Sensitive (OFS) in Tension-type Headache.
ClinicalTrials.gov ID: NCT05229224
What this study is testing
- What it's testing
- The hypothesis of the study is the Osteo-fluidic-Senstive is effective for lowering headache pains (Reduction of the number of days of headaches per month) for patients having frequent episodic tension-type headache. The OFS method will improve quality of life and will reduce the consumption of crisis treatments.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- 18 and 75 years' old
- Person having highly frequent episodic tension type headache (between 2 and 14 days of headaches per month) associated or not to headache with...
- Person who completed his headache agenda the month before the study.
- Patient who understands and accepts the effects of the study
- Signed consent
You likely can't join if
- Person having secondary or primary headaches (chronic tension type headache, migraines only, Cluster headaches, Neuralgias ...)
- Person on treatment of venlafaxine, gabapentine, duloxetine, clomipramine et toxine botulique.
- Concomitant participation to another clinical research
- Pregnant or lactating women, women of child-bearing age who do not have effective contraception.
- People with reinforced protection (juvenile), people deprived of liberty per justice or administrative decision, people living in a sanitary and...
See the full eligibility criteria
- 18 and 75 years' old
- Person having highly frequent episodic tension type headache (between 2 and 14 days of headaches per month) associated or not to headache with characteristic of a migraine per International Classification of Headache...
- Person who completed his headache agenda the month before the study.
- Patient who understands and accepts the effects of the study
- Signed consent
- Person with health insurance coverage
- Person having secondary or primary headaches (chronic tension type headache, migraines only, Cluster headaches, Neuralgias ...)
- Person on treatment of venlafaxine, gabapentine, duloxetine, clomipramine et toxine botulique.
- Concomitant participation to another clinical research
- Pregnant or lactating women, women of child-bearing age who do not have effective contraception.
- People with reinforced protection (juvenile), people deprived of liberty per justice or administrative decision, people living in a sanitary and social establishment, adults under legal protection and people in critical...
The study team makes the final eligibility decision.
Where it's taking place
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.